It remains largely unclear how stem cells regulate bioenergetics and genome integrity to ensure tissue homeostasis. Here, our integrative gene analyses suggest metabolic and genotoxic stresses may underlie the common functional defects of both fetal and adult hematopoietic stem and progenitor cells (HSPCs) upon loss of DPY30, an epigenetic modulator that facilitates H3K4 methylation. DPY30 directly regulates expression of several key glycolytic genes, and its loss in HSPCs critically impaired energy metabolism, including both glycolytic and mitochondrial pathways. We also found significant increase in DNA breaks as a result of impaired DNA repair upon DPY30 loss, and inhibition of DNA damage response partially rescued clonogenicity of the DPY30-deficient HSPCs. Moreover, CDK inhibitor p21 was upregulated in DPY30-deficient HSPCs, and p21 deletion alleviated their functional defect. These results demonstrate that epigenetic mechanisms by H3K4 methylation play a crucial role in HSPC function through control of energy metabolism and protecting genome integrity.
INTRODUCTION
Adult tissue stem cells, including hematopoietic stem and progenitor cells (HSCs and HPCs, or HSPCs) , usually remain in the quiescent state with limited cell divisions, but can enter rapid proliferation upon activation (Kondo et al., 2003) . As one of the most fundamental processes of all lives, metabolism profoundly influences the fate determination of stem and progenitor cells (Ito and Suda, 2014) . Quiescent
HSCs have relatively inactive mitochondria and mainly rely on glycolysis, but rapidly switch to mitochondrial oxidative phosphorylation as the major energy supply when they undergo activation and differentiation (Ito and Suda, 2014) . Regulatory mechanisms in gene expression, including epigenetic mechanisms, can play an important role in stem and progenitor cell fate determination through impinging on the expression of rate-limiting enzymes in the metabolic pathways. Histone H3K4 methylation is one of the most prominent epigenetic marks associated with active gene expression (Shilatifard, 2008) , but its role in regulation of metabolism, especially in stem and progenitor cell settings, remains unclear.
Maintaining the stability of the genetic material through the intricate network of DNA damage response (DDR) is particularly crucial for stem and progenitor cells to ensure the propagation of correct genetic information throughout the daughter cells in the tissue for the benefit of the whole organism (Blanpain et al., 2011) . Mice deficient of components in either recognition (Ito et al., 2004) or repair (Nijnik et al., 2007; Rossi et al., 2007) of DNA lesions often have defective HSCs. As DDR occurs in the context of chromatin, it is thus governed by epigenetic mechanisms regulating chromatin structure and accessibility (Lukas et al., 2011) . In addition to the well-established association with active gene expression, a role of H3K4 methylation in regulating genome stability is also gradually emerging (Burman et al., 2015; Faucher and Wellinger, 2010; Herbette et al., 2017; Higgs et al., 2018) .
The most notable H3K4 methylation enzymes in mammals are the SET1/MLL complexes (Shilatifard, 2008) , which comprise one of six different catalytic subunits and several shared core subunits including DPY30. DPY30 directly facilitates genome-wide H3K4 methylation (Jiang et al., 2011) and plays important roles in the fate transition between pluripotent and differentiated states (Jiang et al., 2011; Yang et al., 2015) . We have further shown a crucial role of DPY30 in HSPCs and animal hematopoiesis (Yang et al., 2014) . Ablation of Dpy30 in the hematopoietic system of the adult mouse bone marrow (BM) leads to loss of global H3K4 methylation, and disables differentiation and long-term maintenance of adult HSCs (Yang et al., 2016) . This is shown in part by the striking accumulation of phenotypic HSCs and early HPCs at the expense of more downstream hematopoietic cells after Dpy30 ablation in BM (Yang et al., 2016) , a phenotype shared by loss of other subunits of the SET1/MLL complexes (Arndt et al., 2018; Chen et al., 2014; Chun et al., 2014; Santos et al., 2014) . Moreover, DPY30-deficient adult HSCs contribute poorly to all hematopoietic cell populations in the later stage after transplant. The normal transition of gene program between cell populations is also disrupted, and multiple genes important for HSC maintenance and differentiation are dysregulated following DPY30 loss (Yang et al., 2016) .
However, it is unclear what pathways are fundamentally important for DPY30's role in HSPC fate determination.
As fetal and adult HSCs differ in many aspects including cell cycle regulation, self-renewal potential, surface marker expression and reconstitution ability (Orkin and Zon, 2008) , the function of DPY30 and H3K4 methylation in prenatal HSCs is still unknown. We reason that pathways fundamentally important for the activity of an epigenetic modulator are likely to be conserved in different biological systems. In this work, we first revealed a similar requirement of DPY30 in the activation and long-term maintenance of fetal HSPCs as compared to the adult HSPCs. Our dissection of targets shared in these two systems allowed us to identify energy metabolism and DDR as fundamentally important mediators of the H3K4 methylation pathway in hematopoiesis, as further supported by our rescue assays.
RESULTS

DPY30 deficiency in fetal liver results in anemia and accumulation of early HSPCs
We previously generated a Dpy30 conditional knockout (KO) mouse model where the Floxed (F) allele of Dpy30 is converted to a null allele upon Cre activity (Yang et al., 2016) . Based on this and the VavCre (Stadtfeld and Graf, 2005) mouse models, here we generated Dpy30 F/+ , Dpy30 , and Vav-Cre; Dpy30 F/+ fetuses. We confirmed Dpy30 excision ( Figure   S1A ) and dramatic reduction of Dpy30 mRNA ( Figure 1B ) in total and various HSPC populations (see Table S1 for cell surface markers) of the Vav-Cre; Dpy30 F/-fetal liver (FL), and reduction of the DPY30 protein ( Figure 1C ) in total FL. DPY30 loss also resulted in marked reduction in H3K4 tri-methylation (H3K4me3) and mild reduction in H3K4 mono-and di-methylation ( Figure 1C ).
While the number of total mononuclear FL cells was unaffected, we consistently detected a striking accumulation ( Figures 1D, S1B , and S1C), in absolute number and frequency, of lineage negative (Lin S1G ). We also established a mixed FL-BM chimeras assay and induced Dpy30 excision by injection of
Polyinosinic-polycytidylic acid (pIpC) into recipients after stable engraftment of the donor FLs carrying
Mx1-cre (Yang et al., 2016) (Figure 1F ). At two weeks after pIpC injection, Dpy30 deletion had mild or no effects on donor contribution to early HSPCs, but significantly reduced that to oligopotent HPCs, developing T cells in thymus and B cells in spleen, and mature blood cells in PB ( Figure 1G ), consistent with a multi-lineage differentiation defect. At twelve weeks after pIpC injection, we detected a dramatic reduction in the contribution of the KO donor cells to all cell populations including HSCs ( Figure 1G ).
Taken together, these results demonstrated an essential role of DPY30 for FL HSC differentiation and long-term maintenance, similar to its role in adult hematopoiesis (Yang et al., 2016) .
Differential and common regulation of gene expression in fetal liver and adult bone marrow HSCs upon Dpy30 ablation
The largely similar phenotypes of the Dpy30 KO FL and BM HSCs suggest that DPY30 and certain DPY30 targets are fundamentally important in regulating HSCs regardless of the developmental stages.
However, we found that DPY30 loss in FLs did not reduce the expression of some key regulatory genes for adult HSC differentiation and maintenance (Yang et al., 2016 ) ( Figure S2A ). As shown by RNA-seq analysis on FL LT-HSCs (Table S2) , genes downregulated upon DPY30 loss in FLs were enriched in many different functions, and those upregulated were enriched in membrane proteins and immune functions ( Figure S2B ). In the 275 and 577 genes downregulated over two fold upon DPY30 loss in FL and BM HSCs, respectively, only 21 genes were shared, with no significant enrichment of pathways ( Figure S2C and Table S2 ). The number of shared genes increased to 95 when we used 1.5-fold cutoff, with an enrichment of nucleotide excision repair genes and mitochondrial genes ( Figure S2E and Table   S2 ). Meanwhile, in the 340 and 669 genes that were upregulated over two fold upon DPY30 loss in FL and BM HSCs, respectively, 41 genes were shared ( Figure S2D and Table S2 ). The number of shared genes increased to 138 when we used 1.5-fold cutoff, with the most significant enrichment in inflammation-related genes ( Figures S2D and S2F ). This suggests cellular stresses upon loss of DPY30 in both FL and BM HSCs, which is also reflected by the specific and dramatic upregulation of Cdkn1a (p21) in both types of HSCs as well as BM myeloid progenitors ( Figures 1H, 1I , and S2G), a gene wellknown to be induced by a wide spectrum of stress stimuli including genotoxic, metabolic, and oxidative insult (Gorospe et al., 1999) . Indeed, several genes involved in redox homeostasis, such as Alox5, Cybb (Nox2), and Xdh, were commonly upregulated in both types of HSCs upon DPY30 loss (Table S2) .
Together with the enrichment of DNA repair and mitochondrial genes being commonly downregulated upon DPY30 loss, these results prompted us to further study the effect of DPY30 loss on the metabolic state and DNA integrity of HSCs.
DPY30 is important for glucose metabolism in HSPCs through direct regulation of key glycolytic genes
We efficiently deleted Dpy30 in various populations of hematopoietic cells (including HSCs) in the BM of Mx1-Cre; Dpy30 F/-mice ( Figure S3A ). Consistent with metabolic stress, both immunoblotting and flow cytometry analyses showed a strong increase in phosphorylation of AMPK at Thr172, a well-established sensor and responder of low nutrient or energy (Lin and Hardie, 2018) , in all different hematopoietic cell populations following DPY30 loss (Figures 2A and 2B) . Moreover, phosphorylation of ACETYL-COA CARBOXYLASE (ACC) at Ser79, one of AMPK's substrates upon AMPK activation, also increased in DPY30-deficient BM (Figure 2A) . These results suggest an activation of the cellular sensor of low nutrient or energy in response to DPY30 deficiency.
We then examined the impact of deficiency of DPY30 and H3K4 methylation on glucose metabolism, a major constituent of cellular energy pathway. DPY30 loss in BM and FL HSCs resulted in downregulation of several genes encoding key glycolytic enzymes, including a number of rate-limiting ones, such as HEXOKINASE (HK1 and HK2), PHOSPHOFRUCTOKINASE MUSCLE (PFKM), and PYRUVATE KINASE LIVER AND RBC (PKLR) (Figures 2C, S3B , and S3C). DPY30 and H3K4me3 were enriched at the transcription start sites of these genes in the Lin -BM in the control mice, but both signals were significantly reduced in the KO littermates ( Figures 2D and 2E ). These results indicate that DPY30, likely through its activity in facilitating H3K4 methylation, directly regulates the expression of these key glycolytic genes.
HEXOKINASE phosphorylates glucose to form glucose 6-phosphate. This reaction is important in promoting continuous uptake of glucose into the cell, as it keeps the glucose concentration low and also prevents glucose from diffusing out of the cell due to the added charge of the reaction product. We thus predicted that downregulation of Hk1 and Hk2 would impair glucose uptake. Indeed, as measured by glucose analog (2-NBDG) uptake by sorted LSK cells, we found that glucose uptake was consistently impaired in HSPCs by DPY30 deficiency ( Figure 2F ). This impairment is probably not a result of reduced glucose transporter expression, as we did not find any significant downregulation of known glucose transporter genes (Table S2) . S3F) . However, at 12 weeks after Dpy30 deletion, we failed to observe any rescue for any cell populations ( Figure S3F ). These results suggest that regulation of Pklr expression by DPY30 functionally contributes to, but is far from the entirety of, the hematopoietic control by DPY30.
DPY30 regulates oxidative energy metabolism of the stem cells
Considering the dysregulation of genes involved in redox homeostasis, we next examined the impact of DPY30 deficiency on oxidative energy metabolism. Real-time measurement of oxygen consumption showed that DPY30 deficiency significantly reduced both the basal and the total oxidative capacity of Lin -progenitors ( Figure 3A) , as well as the extracellular acidification rate ( Figure 3B ). We also found that (Figure S4D ), while primary mouse embryonic fibroblasts (MEFs) showed minimal alteration in ROS level upon DPY30 loss ( Figure S4E ). All these results indicate that DPY30 plays an important role in maintaining the activity of mitochondria and the oxidative energy metabolism. We found that the cellular ATP level was not significantly affected by DPY30 deficiency (Figure 3G ). While NADP/NADPH ratio was unaffected, NAD + /NADH ratio was modestly but significantly increased (Figure 3H) , suggesting a dysregulated redox homeostasis in DPY30-deficient HSPCs.
To examine the functional relevance of ROS increase in the lineage-committed BM cells to pancytopenia of the DPY30-deficient animals, we administered N-acetyl-cysteine (NAC), a potent antioxidant, into these animals. We found that while NAC only slightly but insignificantly improved the survival of KO mice ( Figure S4F ), it significantly (yet partially) and selectively rescued the concentration of the red blood cells in PB of the KO mice ( Figure S4G ). We also induced ex vivo Dpy30 deletion in isolated Lin + BM, and found that NAC treatment in cultured BM ameliorated the apoptotic response of erythroid cells that was increased by Dpy30 deletion, but did not affect the proliferation of Lin + cells that was reduced by Dpy30 depletion ( Figure S4H ). These results suggest that increase of ROS level in the lineage-committed cells functionally contributes to the reduced erythroid cell production upon DPY30 loss.
DPY30 regulates the quiescent state of the stem cells
Considering the intimate connection of HSC energy state and its cell cycle regulation, we further studied how DPY30 deficiency might affect the HSC cell cycle. We previously showed that DPY30 deficiency did not significantly affect the proliferative capacity of HSCs or LSK cells as measured by short-time incorporation of nucleotide analog BrdU (Yang et al., 2016) . Here we analyzed the proliferative state of the HSCs by staining of KI-67, a nuclear protein not only strictly associated with cell proliferation (Scholzen and Gerdes, 2000) but also functionally crucial for successful cell division (Cuylen et al., 2016) .
DPY30 deficiency resulted in significant increase in the percentage of HSCs in G0 stage but not in the S/G2/M of the cell cycle ( Figures 3I and 3J ), suggesting that DPY30-deficient HSCs were in an aberrant and more deeply quiescent state of cell cycle compared to the control HSCs.
DPY30 and H3K4 methylation are important for genome integrity of cells
We then focused on genotoxic stress upon DPY30 loss. We found a significant increase in the γ-H2AX level in the FL and Lin -BM cells upon DPY30 loss in vivo ( Figure 4A ), suggesting breach of genome integrity and increase in DDR. We also directly demonstrated a significant increase in DNA breaks following DPY30 loss in early BM HSPCs by using the comet assay ( Figures S5A and S5B Figure S5C ) and global H3K4 methylation ( Figure S5E and immunoblotting results shown before (Yang et al., 2018) Figures 4B-4G , S5F, and S5G), and monitored DDR and DNA damage levels using nuclear γ-H2AX foci and comet assays ( Figure 4B ). Alternatively, we also irradiated the Dpy30-deleted Lin -BM cells and monitored ATM activation reflected by the level of the phosphorylated KAP1 (an ATM substrate) ( Figure 4F ). Compared to control HSPCs, the Dpy30-deleted HSPCs had significantly higher levels of DNA breaks (by comet assays, Figure 4E and S5G) as well as DDR (by nuclear γ-H2AX foci, Figures 4D and S5F , and phosphorylated KAP1, Figure 4G ) both before and after irradiation. These results indicate that DNA repair capacity is significantly impaired in cells deficient of DPY30 and H3K4 methylation, thus leading to sustained DNA damage and DDR.
Inhibition of DDR partially rescues the function of the DPY30-deficienct HSPCs
We first confirmed that 4-OH-tamoxifen treatment of CAG-CreER; Dpy30 F/F Lin -BM cells greatly reduced their Dpy30 expression ( Figure 5A ) and capacity in forming all different types of colonies ( Figures 5B   and 5C ). We then showed that, while the ATM inhibitor (KU55933) treatment had no effect on the clonogenicity of the control cells, it partially but significantly rescued the ability of the Dpy30-deleted cells in forming all different types of colonies ( Figures 5C-5E ). Moreover, pharmacologic inhibition of ATR and CHK1, but not CHK2, also significantly enhanced the clonogenicity of the Dpy30-deleted Lin -BM cells in a dose-dependent manner ( Figure S6 ). These results suggest that the sustained DDR functionally affects HSPC activities.
We also attempted to rescue the function of the DPY30-deficient HSC in vivo by suppressing DDR. To this end, we have not been able to rescue the hematopoietic defects of DPY30-deficient mice by in vivo administration of ATM inhibitor based on peripheral blood profiling. However, the mitochondrial membrane potential, which was reduced by DPY30 loss, was consistently (though did not reach statistical significance) increased by DDR suppression in the DPY30-deficient mice, although such increase was mainly mediated by an apparently new population of cells among the phenotypic HSCs in these mice (Figures 5F-H) . These results suggest a connection of the DDR, energy metabolism, and HSPC function, all under the control of the epigenetic regulator DPY30.
Induction of p21 is partially responsible for the functional defects of the DPY30-deficient HSPCs
Considering the established role of P21 in regulation of cell cycle and stem cell quiescence in response to metabolic and genotoxic stresses, we next sought to determine if the specific and dramatic elevation of p21 expression played a role in HSC defect upon DPY30 loss. We generated Dpy30
Cre mice, which, upon pIpC injection, became Dpy30 and p21 double KO in the hematopoietic system.
p21 KO had no effect on the numbers or frequencies of any hematopoietic cell populations when DPY30 was present. However, upon Dpy30 deletion, which caused severe accumulation of early HSPCs, p21
KO significantly alleviated the aberrant accumulation of phenotypic LSK cells (Figures 6A and S7A ).
We then transplanted donor BM from the Dpy30 
DISCUSSION
Together with our previous results (Yang et al., 2016) , the data in this work support a model for the role of DPY30 in fetal and adult HSPCs through regulation of energy metabolism and genome integrity (Figure 7) . In normal HSPCs, DPY30, via its activity in facilitating H3K4 methylation, ensures the HSPC functionality through multiple pathways. These pathways include expression of key regulatory genes for adult HSC maintenance (Yang et al., 2016) and likely a different set of regulatory genes for fetal HSC maintenance, expression of key metabolic genes to maintain appropriate bioenergetic pathways, and safeguarding genome integrity through promoting efficient DNA repair. In the absence of DPY30 and efficient H3K4 methylation, expression of genes in many of these pathways is dysregulated, leading to dysregulation of energy metabolism and increase in DNA damage. The impairment in glycolysis may affect HSC maintenance, and the impairment in mitochondrial function may disable HSC activation.
These stresses induce responses including P21 and other inflammatory pathways, which will suppress the activity of HSPCs and lead to attrition of stem cells in the long term. Considering that loss of SETD1A, one of the catalytic subunits responsible for the bulk level of cellular H3K4 methylation, increases the sensitivity of HSCs to inflammatory challenges (Arndt et al., 2018) , we cannot formally exclude the potential complications by the inflammation-driven Dpy30 ablation by the Mx1-Cre system. However, our conclusions were supported by alternative methods of Dpy30 ablation in this and previous studies (Yang et al., 2016) .
We note that our gene analyses for BM used cells from donor-derived cells in the transplant recipients (Yang et al., 2016) , while those for FL here used cells in a homeostatic setting without transplant. Loss of the Setd1a also leads to decrease in ROS in HSCs, although the effect on mitochondrial function was not examined (Arndt et al., 2018) . Our data show that the differential increase of ROS in lineagecommitted cells functionally contributes to the reduced erythropoiesis in the DPY30-deficient animals as it can be partially rescued by antioxidant treatment, but we do not know the functional impact of the abnormally low level of ROS on HSPC activity. It appeared that the DPY30-deficient HSCs in both FL and BM made an effort to increase ROS level by upregulating expression of ROS-producing enzymes, suggesting a need to maintain a certain level of ROS for normal HSC function. This is consistent with previous findings that moderate levels of intracellular ROS are needed to activate DNA repair pathway and maintain genomic stability in stem cells (Li and Marban, 2010) , and also to support HSC proliferation, differentiation, and mobilization (Chaudhari et al., 2014) .
The important function of DPY30 and H3K4 methylation in efficient DNA repair is likely mediated through two non-exclusive mechanisms. First, DPY30 and H3K4 methylation are important for appropriate expression of certain DNA repair genes. This echoes the finding that SETD1A loss also impairs DNA repair capacity and results in increased DNA breaks, probably due to reduced H3K4 methylation and expression of multiple DNA repair genes (Arndt et al., 2018) . Interestingly, efficient DDR gene expression in leukemia cells requires not the H3K4 methylation activity, but a novel region of SETD1A that binds to CYCLIN K, and H3K4 methylation at the DDR genes was sustained by other methylases in the absence of SETD1A in leukemia cells (Hoshii et al., 2018) . Second, H3K4 methylation may directly regulate DNA repair through impact on the chromatin setting at the damaged sites. H3K4 methylation plays an important role in efficient DNA repair in yeast (Faucher and Wellinger, 2010) and C. elegans (Herbette et al., 2017) , but may also predispose chromatin for DNA double stranded breaks through decondensing local chromatin (Burman et al., 2015) . As DPY30-associated H3K4 methylation is functionally important for chromatin accessibility (Yang et al., 2018) , it may regulate the efficiency of DNA repair by promoting the accessibility of DNA repair proteins. In addition to facilitating DNA repair, H3K4 methylation may also protect nascent DNA from degradation in replication stress (Higgs et al., 2018) , thereby contributing to the maintenance of genome stability. Our results also suggest that it is the response to DNA damage, rather than the damage itself, that results in the inactivity of HSPCs. While suppression of DDR can temporarily rescue the function of HSPCs, we speculate that it would have a long-term consequence on the system with uncleansed HSPCs containing damaged genetic information.
In line with P21 being important in maintaining HSC quiescence (Cheng et al., 2000) , its level is uniquely Taken together, our results demonstrate a profound control of HSPC fate determination by a key chromatin modulator via regulating energy metabolism and genome integrity. The functional interplay among the metabolic regulation, ROS level, DDR, and the HSPC activities warrants further studies.
Considering a critical role of DPY30 in MLL-rearranged leukemogenesis (Yang et al., 2014) and MYCdriven lymphomagenesis (Yang et al., 2018) , it will be of great interest to investigate whether and how inhibition of this key epigenetic modulator affects cellular metabolism and genome integrity as part of mechanisms underlying cancer suppression.
EXPERIMENTAL PROCEDURES Animals
All animal procedures were approved by the Institutional Animal Care and Use Committee at the University of Alabama at Birmingham. All mice were maintained under specific pathogen free conditions and housed in individually ventilated cages. Dpy30 +/-mice were generated in our laboratory as previously reported (Yang et al., 2016) 
NADP/NADPH-Glo Assay and GSH/GSSG-Glo Assay Luminescent Cell Viability Assay kits (all from
Promega, Madison, WI), respectively, according to manufacturer's instructions. To determine total cellular ATP levels, BM LSK cells were sorted and assessed using a CellTiter-Glo Luminescent Cell Viability Assay kit (Promega Corporation).
Flow cytometry for analysis and cell isolation
Single cell suspensions were prepared from FL, BM, thymus, spleen, or peripheral blood and stained with antibodies as previously described (Yang et al., 2016) .
Statistics
Unless indicated in the figure legends, the unpaired 2-tailed Student's t-test was used to calculate P values and evaluate the statistical significance of the difference between indicated samples. A P value less than 0.05 was considered significant. Four groups comparison was analyzed by one-factor ANOVA as indicated in figure legends. If ANOVA was overall significant, post hoc t test was used for pairwise comparisons of interest.
Data availability
The RNA-seq data have been deposited in Gene Expression Omnibus database with the accession number GSE101856. )-derived HSCs in the BM chimera recipients in two independent BM transplantations (TP1 and TP2) from our previous work (Yang et al., 2016) .
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Data are shown as mean +SD for (C-E). *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001, by 2-tailed
Student's t-test.
See also Figures S1-S2. to Hbb for genomic DNA levels. n=3 mice each.
(G and H) Total cellular ATP levels (G), and NAD + /NADH and NADP + /NADPH ratios (H) in BM LSK cells
were determined. n=3 mice each.
(I) Representative FACS plots of KI-67 staining on LT-HSCs.
(J) G0, G1, and S/G2/M phases of LT-HSCs were quantified. n = 5 mice each.
Data are shown as mean +SD for all panels. n.s. not significant, *P<0.05, **P<0.01, ***P<0.001, by 2-
See also Figure S4 . Figure S5F .
(E) Comet assay on LSK cells. We used 4 classes of cell morphology to show increasing DNA damage severity, and quantified (bottom) the percentages of each class before and after irradiation.
(F) Assay scheme and the mouse genotype legend for (G). Tamoxifen-treated Lin -BM were irradiated, followed by FACS assays gated on LSK cells at different time points. n=3 mice each. See also Figure S5 . See also Figure S6 . 
test (A) and 2-tailed Student's t-test (C) and (D).
See also Figure S7 . 
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• Supplemental figures 1-7 and legends
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• Supplemental experimental procedures
• Supplemental references In panels (C-G) , the BM HSC data are based on RNA-seq results in donor (Mx1-Cre; Dpy30 F/+ or Mx1-Cre; Dpy30 F/-) -derived HSCs in the BM chimera recipients in two independent BM transplantations (TP1 and TP2) from our previous work (Yang et al., 2016) . (E and F) Venn diagram for genes that were downregulated (E) or upregulated (F) over 1. Figure 6B . Related to Figure 6 . F/-(KO) fetuses, each pair from the same litter, at E14.5 were sorted out for RNA-Seq. Gene expression data for the bone marrow (BM) HSCs are from our previous work (Yang et al., 2016) and are included here for convenience of comparison. The BM data are from two transplant (TP1 and TP2) recipients at two weeks after pIpC induction. These TP recipients received Mx1-Cre; Dpy30 F/+ (control) and Mx1-Cre; Dpy30 F/-(KO) donor BM cells and were then injected with pIpC. Compared to control, genes up-or down-regulated more than 2 (or 1.5) fold in both BM TPs are shown in tabs "BM up>2 (or 1.5)" and "BM down>2 (or 1.5)". All normalized FL HSC RNA-Seq data with three fetuses of each genotype are listed in tab "All genes in FL HSC". Genes up-or down-regulated in FL HSCs with mean value more than 2 fold and p <0.05 are listed in tabs "FL down >2" and "FL up>2". Genes up-or down-regulated more than 1.5 fold in all three littermate pairs are listed in tabs "FL down >1.5" and "FL up>1.5". Tabs "BM & FL down>2 (or 1.5)" show overlapping genes between tabs "BM down>2 (or 1.5)" and "FL down >2 (1.5)". Tabs "BM & FL up>2 (1.5)" show overlapping genes between tabs "BM up>2" and "FL up>2". ) at a ratio of 5:1, and transplanted into recipient mice in the same way as described above. Recipients were then injected with 150 µl pIpC (InvivoGen) at 1 mg/ml 4 times over 10 days starting at 5 weeks post transplantation. The first two injections were 2 days apart and last injections were 4 days apart. Reconstitution levels were assessed at different time points after pIpC injection. Prior to transplant, all of the recipient mice were lethally irradiated with a split dose of 1100 Rads with 3 hours apart. Donor contribution was determined by flow cytometry at different time points and calculated by CD45.2 + /(CD45.1 + + CD45.2 + ) × 100% within the indicated cell type except for the Pklr rescue assay, where the donor contribution was calculated by GFP + /(GFP + + CD45.1 + ) × 100%. For the Pklr rescue assay, the mouse Pklr cDNA was cloned with Nterminal FLAG tag into pMSCV-IRES-GFP (Addgene, #20672) between EcoRI and XhoI sites to generate the FLAG-Pklr-expressing plasmid. To generate the retroviruses, 293T cells were transiently transfected with either empty pMSCV-IRES-GFP vector or the FLAG-Pklr-expressing construct with pCL-Eco plasmid using Lipofectamine 2000 (Invitrogen), and viruses in the supernatants were harvested two days after transfection. Four days after injecting both Dpy30 F/+ ; Mx1-Cre and Dpy30 F/-; Mx1-Cre mice (6-8-week old) with 150 mg/kg 5-fluorouracil (5-FU, Sigma-Aldrich), BM cells were flushed from these mice and were incubated overnight in RPMI 1640 with 20% fetal calf serum, 20 ng/ml SCF, 20 ng/ml Flt-3, 10 ng/ml IL-3 and 10 ng/ml IL-6 (all from Peprotech, Rocky Hill, NJ) at 37ºC to promote cell cycle entry. Cells were then spinoculated with retroviral supernatant in the presence of 8 μg/ml polybrene (Clontech, Mountain View, CA) for 90 minutes at 500 x g at 30°C. 
SUPPLEMENTAL TABLES
Flow cytometry for analysis and cell isolation
Single cell suspensions were prepared from FL, BM, thymus, spleen, or peripheral blood and stained with antibodies as previously described (Yang et al., 2016) . FACS analysis was performed on LSRFortessa (Becton Dickinson), and data were analyzed using FlowJo software (Tree Star) as previously described (Yang et al., 2016) . Cells were fixed, permeablized and immunostained with antiphospho-AMPKα (Thr172) antibody (Cell Signaling Technology, #2535), or phospho-KAP-1 (S824) (Bethyl Laboratories, #A300-767A). Mean fluorescence intensity was determined. To measure mitochondrial membrane potential and mitochondrial mass, the HSC staining was modified to make the channels available for tetramethyl rhodamine methyl ester (TMRM) and Mitotracker Deep Red staining (all from Molecular Probes), respectively. After antibody staining cells were incubated with 25 nM TMRM or 1nM Mitotracker Deep red for 15 min at 37ºC followed by flow-cytometry on LSRFortessa (Becton Dickinson), respectively. To measure cellular ROS levels, cells were incubated with 5 mM 2`-7`-dichlorofluorescein diacetate (DCFDA) at 37ºC for 15 min after being stained with the antibodies as described. ROS levels in the gated populations were quantified using flow cytometry. To measure the glucose uptake, 3×10 4 sorted BM LSK cells were incubated with 100 µM 2-NBDG at 37ºC for 1 hour in RPMI-1640 (Life Technologies, no glucose) containing 10% FBS, 100 ng/mL SCF and 100 ng/mL Flt-3. Cellular glucose uptake levels were quantified using flow cytometry. FACS sorting from BM cells was performed as we previously described (Yang et al., 2016) . FACS sorting from FLs was performed on LSRAria II (Becton Dickinson). Briefly, 2-3 embryos were pooled and stained with lineage cocktail containing biotin-conjugated antibodies against CD3e (145-2C11), CD4 (GK1.5), CD5 (53-7.3), CD8 (53-6.7), CD45R (RA3-6B2), Gr1 (RB6-8C5) and Ter119 (TER-119), and the following antibodies to discriminate FL HSC: Sca1 (D7)-PE-Cy7; CD117 (c-Kit 2B8)-PE; CD48 (HM48.1)-FITC; CD150 (TC15-12F12.2)-Pacific blue. All fluorescence-conjugated antibodies were obtained from BioLegend Inc.
Colony formation assays
Lin -FL cells were enriched by staining with lineage cocktail containing biotin-conjugated antibodies against CD3e (145-2C11), CD4 (GK1.5), CD5 (53-7.3), CD8 (53-6.7), CD45R (RA3-6B2), Gr1 (RB6-8C5) and Ter119 (TER-119), and the following anti-biotin microbeads (Milteni Biotec, . Lin -BM cells were enriched by Lineage Cell Depletion Kit (Milteni Biotec, . pLKO.1-based lentiviral constructs expressing scramble control (Addgene plasmid 1864) or short hairpins (shRNAs) targeting indicated genes were transfected into 293T cells, respectively. Viral particles were produced as we described (Yang et al., 2014) . Lin -BM and Lin -FL cells were harvested as described above and incubated overnight prior to infecting with unconcentrated viruses in the presence of 4 µg/ml of polybrene (Sigma). Two days after infection, puromycin (1 µg/ml) was added, and 2 more days later, cells were used for various assays including RNA isolation and colony formation assay. Indicated numbers of cells were plated in duplicate or triplicate into 1.1 ml Mouse Methylcellulose Complete Media (STEMCELL Technologies, M3434). Colonies were scored at 7-10 days after plating.
DNA damage assays
Primary mouse embryonic fibroblasts (MEFs) were isolated from E13.5 embryos of Dpy30 F/F or CAGCreER; Dpy30 F/F genotype, cultured in MEF culture medium (Dulbecco's Modified Eagle Medium [DMEM] supplemented with L-glutamine, 10% FBS, 0.1 mM non-essential amino acids, and 55μM β-mercaptoethanol, all from Invitrogen), and passage was kept at minimum. MEFs were treated with vehicle (ethanol) as control or 0.5 µM of 4-OH tamoxifen for 4 days to induce Dpy30 deletion. Lin -BM cells were treated with vehicle (ethanol) as control or 0.5 µM of 4-OH tamoxifen for 48 hrs, and were either FACS sorted for LSK cells before irradiation and assays for γ-H2AX staining and comet assay, or directly used for irradiation and flow cytometry analysis for phospho-Kap1. To induce DNA damage, cells were irradiated with 3.2 Gy (X-RAD 320 irradiator; dose rate, 0.8 Gy/min). BM cells were cytospun before immunostaining. Immunostaining was performed using primary antibody for H3K4me3 described before (Jiang et al., 2011; Yang et al., 2015) followed by Alexa Fluor 555 Goat anti-Rabbit IgG (H+L) CrossAdsorbed secondary antibody (ThermoFisher Scientific, # A-21428), and primary antibody for phospho-H2AX (Ser139) (Millipore, #05-636), followed by Alexa Fluor 488 Goat anti-Mouse IgG (H+L) CrossAdsorbed secondary antibody (ThermoFisher Scientific, # A-11001). Comet Assay was performed using the OxiSelect Comet Assay Kit according to the manufacturer's instructions (Cell Biolabs). Images were acquired by a Nikon Ti-S microscope using a FITC filter, and the comet images were analyzed in two ways. For comet assays in Figures 5A and 5B, the percentage of tail DNA of individual cells was determined by the OpenComet (Gyori et al., 2014) plugin of ImageJ. The graph and two-tailed Student's t-test were performed using the GraphPad Prism software. For all other comet assays, we performed visual scoring method that closely correlates with computer scoring method (Collins, 2004) .
For rescue assays by DDR inhibitors in culture, Lin -BM cells from CAG-CreER; Dpy30 F/F mice were treated with DMSO control or indicated inhibitors in liquid culture containing vehicle control (ethanol) or 1 µM of 4-OH tamoxifen for two days and subjected to colony formation assays. ATM inhibitor KU55933 (Sigma, #SML1109) was used at 10 µM in DMSO, and ATR inhibitor VE-821 (Sigma, #SML1415), Chk2 inhibitor PV1019 (Sigma, #220418), and Chk1 inhibitor MK8776 (Cayman Chemical, #891494-63-6) were used at indicated concentration in DMSO. For rescue assays by DDR inhibitors in vivo, mice were injected with pIpC, and either vehicle (DMSO) or KU55933 (10 mM, 50 µl per mouse) was injected intraperitoneally one day prior to the first pIpC injection, and was repeated every two days until the end of the experiment.
NAC effects
For NAC administration in vivo, Mx1-Cre; Dpy30 F/+ and Mx1-Cre; Dpy30 F/-mice were injected with pIpC as previously described (Yang et al., 2016) , and NAC (Sigma, Cat# A7250) was meanwhile supplied in drinking water at 2 mg/ml. Fresh NAC drinking water was replace every two days until the end of the experiment. For NAC treatment in cultured cells, Fresh Lin + BM cells were enriched as described (Yang et al., 2016) . The cells were then incubated with 1 µM of 4-OH tamoxifen or/and 1 µM of NAC for 2 days as indicated.
Proliferation and apoptosis HSPC proliferation and apoptosis were determined as previously described (Yang et al., 2014; Yang et al., 2016) with modifications. Briefly, to analyze the cell cycle status of FLs, 1.5 mg Brdu was intraperitoneally injected into E14.5 pregnant mice 1 hour prior to sacrifice. Cells were stained with cell surface antibodies as described above and then processed with BrdU staining using the FITC-BrdU Flow kit (BD Pharmingen) following the manufacturer's instructions. The cells were washed by PBS and then stained with antibodies labeled with various fluorochromes as described. For HSC cycle analysis, fresh BM cells were stained with SLAM cell surface markers as described. Cells were then fixed and permeabilized by the buffers from FITC-BrdU Flow kit (BD Pharmingen) and then stained with FITClabeled anti-Ki67 antibody (BD Biosciences) followed by 7-AAD. Percentages of the cells at G0, G1, and S/G2/M phases were quantified by flow cytometry. For apoptosis assay, cells were harvested and stained with antibodies as described. After washing twice with cold PBS containing 3% heat-inactivated FBS, the cells were then incubated with FITC-Annexin V (BD Pharmingen) and 7-amino-actinomycin D (7-AAD) for 15 minutes in binding buffer (10mM HEPES, 140 mM NaCl and 2.5mM CaCl 2) at room temperature in dark. The stained cells were analyzed immediately by flow cytometry.
RNA extraction, chromatin immunoprecipitation (ChIP) and quantitative PCR (qPCR)
Total RNAs were isolated using RNeasy Plus Mini (for non-HSCs) or Micro (for HSCs) Kit (Qiagen) as described (Yang et al., 2016) . ChIP assays and qPCR were performed as described (Yang et al., 2016) . Primers used are listed in Table S3 . Relative expression levels were normalized to Actb. For ChIP results, percent input was first calculated from ChIP qPCR results as described (Jiang et al., 2011) , and ChIP enrichment fold was calculated as the ratio of the percent input value for each locus over that for the negative control site in the control cells (Mx1-Cre; Dpy30 F/+ ). RNAs were reverse transcribed with SuperScript III (Invitrogen). qPCR was performed with SYBR Advantage qPCR Premix (Clontech) on a ViiA7 Real-Time PCR System (Applied Biosystems). Primers used are listed in Table S3 . Relative expression levels were normalized to Actb. RNA-sequencing and analyses were performed as described before (Yang et al., 2016) .
Immunoblotting
Whole fetal liver cells and bone marrow cells were isolated after removing red blood cells by ACK lysis buffer. The cells were then lysed by lysis buffer (1% SDS, 10mM EDTA and 50mM Tris-Cl pH 7.5) with fresh added Protease Inhibitor Cocktail (Roche) and boiled for 10 min. Proteins were resolved on SDS-PAGE followed by immunoblotting for DPY30, H3, H3K4me1, H3K4me2, and H3K4me3, all using antibodies described before (Jiang et al., 2011; Yang et al., 2015) , and for β-Actin (Santa Cruz Biotechnology, sc-47778), FLAG (Sigma-Aldrich, F3165), phospho-AMPKα (Thr172) (Cell Signaling Technology, #2535), phospho-ACC (Ser79) (Cell Signaling Technology, #3661), and phospho-H2AX (Ser139) (Millipore, . Band intensities were quantified by ImageJ.
